Livzon Pharmaceutical Group Inc. (HKG:1513)
Hong Kong
· Delayed Price · Currency is HKD 29.35
+0.55 (1.91%)
Jun 27, 2025, 4:08 PM HKT
HKG:1513 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 26, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Jan '21 Jan 1, 2021 | 2015 - 2019 |
| Market Capitalization | 32,046 | 32,675 | 31,168 | 31,039 | 39,657 | 39,381 | Upgrade
|
| Market Cap Growth | -5.83% | 4.83% | 0.41% | -21.73% | 0.70% | 27.23% | Upgrade
|
| Enterprise Value | 25,677 | 26,363 | 25,008 | 25,207 | 33,283 | 32,171 | Upgrade
|
| Last Close Price | 29.95 | 26.54 | 21.94 | 22.34 | 22.84 | 23.17 | Upgrade
|
| PE Ratio | 14.30 | 14.90 | 14.48 | 14.38 | 18.19 | 19.33 | Upgrade
|
| PS Ratio | 2.54 | 2.60 | 2.28 | 2.17 | 2.68 | 3.15 | Upgrade
|
| PB Ratio | 1.94 | 2.06 | 1.92 | 1.84 | 2.26 | 2.43 | Upgrade
|
| P/TBV Ratio | 2.19 | 2.30 | 2.10 | 2.08 | 2.56 | 2.82 | Upgrade
|
| P/FCF Ratio | 13.43 | 12.75 | 11.65 | 14.98 | 54.46 | 21.90 | Upgrade
|
| P/OCF Ratio | 10.75 | 10.31 | 8.71 | 9.90 | 16.98 | 15.35 | Upgrade
|
| EV/Sales Ratio | 2.00 | 2.10 | 1.83 | 1.77 | 2.25 | 2.58 | Upgrade
|
| EV/EBITDA Ratio | 7.54 | 8.03 | 8.28 | 8.70 | 11.58 | 11.19 | Upgrade
|
| EV/EBIT Ratio | 8.99 | 9.77 | 11.81 | 11.54 | 14.14 | 13.35 | Upgrade
|
| EV/FCF Ratio | 10.76 | 10.29 | 9.35 | 12.17 | 45.71 | 17.89 | Upgrade
|
| Debt / Equity Ratio | 0.25 | 0.27 | 0.28 | 0.24 | 0.19 | 0.14 | Upgrade
|
| Debt / EBITDA Ratio | 1.24 | 1.28 | 1.50 | 1.40 | 1.14 | 0.80 | Upgrade
|
| Debt / FCF Ratio | 1.73 | 1.65 | 1.71 | 1.98 | 4.54 | 1.27 | Upgrade
|
| Asset Turnover | 0.47 | 0.48 | 0.50 | 0.54 | 0.56 | 0.55 | Upgrade
|
| Inventory Turnover | 2.15 | 2.09 | 2.33 | 2.47 | 2.74 | 2.82 | Upgrade
|
| Quick Ratio | 1.97 | 1.87 | 1.86 | 1.97 | 1.83 | 2.13 | Upgrade
|
| Current Ratio | 2.28 | 2.15 | 2.13 | 2.30 | 2.12 | 2.40 | Upgrade
|
| Return on Equity (ROE) | 15.53% | 15.53% | 12.78% | 13.37% | 13.97% | 16.45% | Upgrade
|
| Return on Assets (ROA) | 6.58% | 6.40% | 4.81% | 5.11% | 5.58% | 6.58% | Upgrade
|
| Return on Capital (ROIC) | 8.55% | 8.39% | 6.41% | 6.79% | 7.36% | 8.69% | Upgrade
|
| Return on Capital Employed (ROCE) | 15.20% | 15.10% | 11.30% | 11.10% | 12.40% | 14.00% | Upgrade
|
| Earnings Yield | 6.99% | 6.71% | 6.91% | 6.95% | 5.50% | 5.17% | Upgrade
|
| FCF Yield | 7.45% | 7.85% | 8.58% | 6.67% | 1.84% | 4.57% | Upgrade
|
| Dividend Yield | 4.08% | 4.41% | 6.78% | 8.09% | 6.99% | 6.41% | Upgrade
|
| Payout Ratio | 63.64% | 65.03% | 81.36% | 83.33% | 70.81% | 64.14% | Upgrade
|
| Buyback Yield / Dilution | 2.04% | 1.10% | 0.56% | 0.04% | 0.25% | -0.41% | Upgrade
|
| Total Shareholder Return | 6.13% | 5.51% | 7.34% | 8.13% | 7.23% | 6.00% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.